Stay updated on NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.8.0 instead of v3.7.2. The study record still displays a 403 error.
    Difference
    0.3%
    Check dated 2026-10-31T13:29:29.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition to using “Super Intelligence” instead of “Artificial Intelligence” across NIH content. The clinical trial page content remains an error page.
    Difference
    1%
    Check dated 2026-10-24T13:04:36.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T13:58:21.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:10:28.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study content with a generic access notice.
    Difference
    19%
    Check dated 2026-09-19T19:25:16.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The footer revision label updated from v3.6.5 to v3.6.6, signaling a small version update. There are no changes to the study content or navigation elements.
    Difference
    0.1%
    Check dated 2026-08-29T22:11:19.000Z thumbnail image

Stay in the know with updates to NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NC-6004+Pembrolizumab Combination in Head & Neck Cancer Clinical Trial page.